Malorni L, Tyekucheva S, Hilbers FS, Ignatiadis M, et al. Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant. Eur J Cancer 2022;164:39-51.
PMID: 35172272